Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.
about
Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementIncidence and prevalence of inflammatory myopathies: a systematic reviewEpidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel WorkshopExpert panel workshop consensus statement on the role of the environment in the development of autoimmune diseaseDeciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.Myositis-specific autoantibodies: detection and clinical associations.Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan.Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.Sex-specific environmental influences on the development of autoimmune diseasesMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Sex differential association of dermatomyositis with Sjögren syndrome.Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.Management of cutaneous dermatomyositis.Autoantibodies in polymyositis and dermatomyositis.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.The EuroMyositis registry: an international collaborative tool to facilitate myositis research.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study.Pharmacological management of dermatomyositis.Environmental factors associated with disease flare in juvenile and adult dermatomyositis.Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?Role of environmental factors in autoantibody production - importance of a detailed analysis in a small cohort.Variation at HLA-DPB1 is associated with dermatomyositis in Chinese population.The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.Current Classification and Management of Inflammatory Myopathies.Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis.Bench to bedside review of myositis autoantibodies.
P2860
Q26744705-6472346E-BD97-4230-A008-D5C87BCF6502Q26999366-28C48C2A-ABCB-4461-B3EB-A212082EB418Q28390922-C81E14FE-35B8-4C1A-A33D-8EF5DE8F7F6AQ28394057-B8774D7A-B6F3-48D9-AF3B-DAE07E17C826Q33717793-A133175E-F0D6-41D1-BF69-E7F835EB9159Q33765938-0132D30E-0F06-47F0-B123-70F089796EA0Q34349952-530F31E1-3275-42E6-BC11-0F05BC0E4E54Q35092898-36523664-7D87-48CB-931A-C7D9148ABE43Q35309808-2D7F9762-FD79-450C-AA9D-E9237A4554F3Q35907850-6DB7D8AD-4CC3-48D9-9D6E-13057EA71EC8Q37056716-07B5FA43-3E4B-4AC1-8FE7-A453BD082B5BQ37248651-12A3EADE-29E9-46F3-8F5A-EA6616557DA3Q37368405-25D12A22-0C76-477E-90D5-C3D755DB4BE3Q37621925-574DEAC4-A1E2-4D43-8860-20D998A13783Q37938701-3456BE31-99C8-453A-A190-5533A0C6AD6AQ38022271-C18214C8-6494-4788-94A5-D88CD547EC64Q38099556-995F0B27-A97C-446C-A743-4B01B19BD799Q38596370-354B6340-975B-4AE4-87CE-03597E165425Q38601741-055A338C-F315-4ABC-9C60-DBC0D88D86C9Q38603422-161F07DD-6911-464D-9762-48A61532C4A4Q38646384-92AFD094-F311-4C48-8296-EC27A5E10FBEQ38761660-6FD8CD2A-6599-45B1-B990-FA40C2F42B0EQ39425296-52C2E94B-6822-437F-9CB2-4E586E4EC8C2Q40237188-6BA92A04-048D-4A44-B620-DF3EE1B17208Q42418314-35715FC8-9143-4207-BC61-3008D842EEC6Q43218594-7162F073-6D7D-4974-BC2C-2A659B9955F5Q47853979-0FD1E8E3-7E24-47C7-9E15-939142BDBAF6Q53688636-9F831507-DB5A-4452-B15A-8B0427D642A2Q54977148-D5FED4BD-C8FA-499F-8416-E5FBBDE0DAA8Q55342126-C68CCDBB-B002-4C14-BA52-F29AEB69807BQ55425108-DD658721-A95E-47E8-B188-4193FB4B6DA4
P2860
Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ultraviolet radiation intensit ...... -Mi-2 autoantibodies in women.
@ast
Ultraviolet radiation intensit ...... -Mi-2 autoantibodies in women.
@en
type
label
Ultraviolet radiation intensit ...... -Mi-2 autoantibodies in women.
@ast
Ultraviolet radiation intensit ...... -Mi-2 autoantibodies in women.
@en
prefLabel
Ultraviolet radiation intensit ...... -Mi-2 autoantibodies in women.
@ast
Ultraviolet radiation intensit ...... -Mi-2 autoantibodies in women.
@en
P2093
P2860
P356
P1476
Ultraviolet radiation intensit ...... -Mi-2 autoantibodies in women.
@en
P2093
Chester V Oddis
Clarice R Weinberg
D Robert McConnaughey
Frank C Arnett
Ira N Targoff
Lori A Love
Thomas A Medsger
P2860
P304
P356
10.1002/ART.24702
P577
2009-08-01T00:00:00Z